Todos os posts
Diretrizes para o tratamento de pacientes com pancreatite aguda grave.
22 Jun, 2022 | 21:29hConteúdos relacionados:
Evidence-Based Disposition of Acute Pancreatitis – emDocs
Pancreatitis – National Institute for Health and Care Excellence
Diretriz ERS sobre suporte ventilatório não invasivo pediátrico de longo prazo.
22 Jun, 2022 | 21:27hERS statement on paediatric long-term noninvasive respiratory support – European Respiratory Journal
Resumo da nova diretriz AHA/ASA 2022 sobre hemorragia intracerebral.
22 Jun, 2022 | 21:26hIntracerebral Hemorrhage 2022 Guideline Update – emDocs
Principais tópicos a saber: 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage – American Heart Association
Comunicado de imprensa: New guideline refines care for brain bleeds: compression socks, some meds not effective – American Heart Association
Definição de consenso e recomendações de tratamento: câncer de bexiga sem invasão muscular de risco intermediário.
22 Jun, 2022 | 21:24hIntermediate-risk Non–muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group – European Urology – Oncology (se o acesso a este link for pago, tente este)
Comentário do autor no Twitter
Intermediate-risk NMIBC: Updated Consensus Definition & Management Recs from IBCG (International Bladder Cancer Group)
Full text: https://t.co/QaqGqRN3AE @drtanws @garysteinbergmd @DrShariat @UrogerliMD @MRoupret @spsutkaMD @joanfundi @MarekBabjuk @SWilliams_MD #bladdercancer pic.twitter.com/XQ1sdhqXPZ— Ashish M. Kamat, MD, MBBS (@UroDocAsh) June 17, 2022
M-A | Comparação de técnicas de bifurcação para intervenção coronariana percutânea.
22 Jun, 2022 | 21:23hEstudo randomizado | Lisocabtagene maraleucel vs. cuidado padrão com quimioterapia de resgate seguida de transplante autólogo de células-tronco como segunda linha de tratamento em pacientes com linfoma B de células grandes recidivante ou refratário.
22 Jun, 2022 | 21:22hLisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial – The Lancet (link para o resumo – $ para o texto completo)
Onconefrologia: atualização da nefrotoxicidade relacionada à medicação anticâncer.
22 Jun, 2022 | 21:20hOnconephrology: Update in Anticancer Drug-Related Nephrotoxicity – Nephron
Conteúdos relacionados:
Comentário da autora no Twitter
Just published! Our review about anticancer drugs related kidney injury with @PepaSolerR and @julianadraibe @SENefrologia @onconephsociety @onconefrologia @senjoven @ERAkidney @womeninnephro https://t.co/jFStKwym5z @KargerPublisher pic.twitter.com/zvbl7wxAbD
— Clara García Carro (@ClaraGCarro) June 20, 2022
Estudo de coorte nacional | Segurança da cirurgia bariátrica em pacientes com eventos coronarianos agudos prévios ou insuficiência cardíaca.
22 Jun, 2022 | 21:18h
Comentário no Twitter
#Bariatric surgery improves metabolic health of patients, but what are the risks if they have had MI before surgery?
National dataset matched 16000 pts🇸🇪
Heart dis assoc w/🔼 cardiac events post op, plus 🔼risk of SBO and stricture.#SoMe4Surgery https://t.co/iHsZiHIgdG pic.twitter.com/v2SXMpcZd3— BJS Open (@BjsOpen) June 17, 2022
Estudo de coorte | Associação de transtorno obsessivo-compulsivo e sintomas obsessivo-compulsivos com uso indevido de substâncias.
22 Jun, 2022 | 21:16h
Comentário no Twitter
In this Swedish cohort study, individuals with OCD diagnosis had a nearly 4-fold risk of substance use disorders, substance-related criminal convictions or deaths. The association was partially accounted for by shared genetics. https://t.co/BDwKw227FG
— JAMA Network Open (@JAMANetworkOpen) June 6, 2022